Chengjiang Li
- Pharmaceutical Science top 2%
- Molecular Biology
- Surgery
- Endocrinology, Diabetes and Metabolism
- Dermatology top 10%
- Co-authors
- Haojie YuLi WangXiang ChenJingyi FengFazal HaqAmin KhanRizwan Ullah KhanWeibin Zhou
- Topics
- Diabetes Treatment and Management (7 papers)Advancements in Transdermal Drug Delivery (6 papers)Pancreatic function and diabetes (6 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chengjiang Li
36 papers receiving 470 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 184
- Molecular Biology 129
- Surgery 87
- Endocrinology, Diabetes and Metabolism 87
- Dermatology 57
Countries citing papers authored by Chengjiang Li
This map shows the geographic impact of Chengjiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjiang Li more than expected).
Fields of papers citing papers by Chengjiang Li
This network shows the impact of papers produced by Chengjiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjiang Li. The network helps show where Chengjiang Li may publish in the future.
Co-authorship network of co-authors of Chengjiang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Chengjiang Li. A scholar is included among the top collaborators of Chengjiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengjiang Li. Chengjiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 13 | |
| 4 | 19 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 127 | |
| 8 | 12 | |
| 9 | 1 | |
| 10 | 19 | |
| 11 | 14 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 16 | |
| 16 | 6 | |
| 17 | 12 | |
| 18 | 5 | |
| 19 | 3 | |
| 20 | 13 |
About Chengjiang Li
Chengjiang Li is a scholar working on Pharmaceutical Science, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 36 papers that have together received 477 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Advancements in Transdermal Drug Delivery (6 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Pharmaceutical Science (184 citations), Dermatology (57 citations) and Drug Discovery (1 citation). Chengjiang Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Haojie Yu, Li Wang, Xiang Chen, Jingyi Feng, Fazal Haq, Amin Khan, Rizwan Ullah Khan, Weibin Zhou, Di Shen and Huali Zhou. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.